Skip to main
IRTC

iRhythm Technologies (IRTC) Stock Forecast & Price Target

iRhythm Technologies (IRTC) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 50%
Buy 42%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

iRhythm Holdings is well-positioned in the digital healthcare industry with its innovative Zio platform that offers more efficient and accurate diagnostic solutions for arrhythmias. The company's recent financial performance, with a revenue beat and gross margin expansion, supports our positive outlook on its growth potential and ability to achieve profitability. Additionally, the company's focus on expanding into new market segments and its strong execution in existing segments suggest continued beat-and-raise performance in the future.

Bears say

iRhythm Holdings is a company with great potential in the digital healthcare industry, but despite its strong revenue growth and profitability, we have a negative outlook on the stock. The potential risk associated with changes to risk-adjusted payment criteria from CMS could impact the company's financial performance and disrupt its growth trajectory. Additionally, the stock's high valuation and potential competition in the space could lead to limited upside for investors.

iRhythm Technologies (IRTC) has been analyzed by 12 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 42% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of iRhythm Technologies and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About iRhythm Technologies (IRTC) Forecast

Analysts have given iRhythm Technologies (IRTC) a Buy based on their latest research and market trends.

According to 12 analysts, iRhythm Technologies (IRTC) has a Buy consensus rating as of May 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $187, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $187, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

iRhythm Technologies (IRTC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.